Sophie Layalle

Dr. Sophie Layalle


Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 October 2005 in Science
Verified
Journal Article
Closed access
PDF file
JCJulien Colombani
Julien Colombani
LBLaurence Bianchini
Laurence Bianchini
SLSophie Layalle
Sophie Layalle
Emilie PondevilleEmilie Pondeville
Emilie Pondeville
CDChantal Dauphin-Villemant
Chantal Dauphin-Villemant
PLPierre Léopold
Pierre Léopold
All animals coordinate growth and maturation to reach their final size and shape. In insects, insulin family molecules control growth and metabolism, whereas pulses of the steroid 20-hydroxyecdysone (20E) initiate major developmental transitions. We show that 20E signaling also negatively controls animal growth rates by impeding general insulin signaling involving localization of the transcription factor dFOXO and transcription of the translation inhibitor 4E-BP . We also demonstrate that the larval fat body, equivalent to the vertebrate liver, is a key relay element for ecdysone-dependent growth inhibition. Hence, ecdysone counteracts the growth-promoting action of insulins, thus forming a humoral regulatory loop that determines organismal size.

1 October 2008 in Developmental Cell
Verified
Journal Article
Closed access
SLSophie Layalle
Sophie Layalle
NANathalie Arquier
Nathalie Arquier
PLPierre Léopold
Pierre Léopold

1 December 2006 in Diabetes
Verified
Journal Article
Open access
PDF file
CGCharles Géminard
Charles Géminard
NANathalie Arquier
Nathalie Arquier
SLSophie Layalle
Sophie Layalle
MBMarc Bourouis
Marc Bourouis
MSMaija Slaidina
Maija Slaidina
PLPierre Léopold
Pierre Léopold
Insulin signaling is a conserved feature in all metazoans. It evolved with the appearance of multicellularity, allowing primordial metazoans to respond to a greater diversity of environmental signals. The insulin signaling pathway is highly conserved in insects and particularly in Drosophila, where it has been extensively studied in recent years and shown to control metabolism, growth, reproduction, and longevity. Because misregulation of the insulin/IGF pathway in humans plays a role in many medical disorders, such as diabetes and various types of cancer, unraveling the regulation of insulin/IGF signaling using the power of a genetically tractable organism like Drosophila may contribute to the amelioration of these major human pathologies.

1 June 2011 in Development
Verified
Journal Article
Closed access
PDF file
SLSophie Layalle
Sophie Layalle
MVMichel Volovitch
Michel Volovitch
BMBruno Mugat
Bruno Mugat
NBNathalie Bonneaud
Nathalie Bonneaud
MPMarie-Laure Parmentier
Marie-Laure Parmentier
FMFlorence Maschat
Florence Maschat
Homeodomain transcription factors classically exert their morphogenetic activities through the cell-autonomous regulation of developmental programs. In vertebrates, several homeoproteins have also been shown to have direct non-cell-autonomous activities in the developing nervous system. We present the first in vivo evidence for homeoprotein signaling in Drosophila. Focusing on wing development as a model, we first demonstrate that the homeoprotein Engrailed (En) is secreted. Using single-chain anti-En antibodies expressed under the control of a variety of promoters, we delineate the wing territories in which secreted En acts. We show that En is a short-range signaling molecule that participates in anterior crossvein development, interacting with the Dpp signaling pathway. This report thus suggests that direct signaling with homeoproteins is an evolutionarily conserved phenomenon that is not restricted to neural tissues and involves interactions with bona fide signal transduction pathways.

Verified
Journal Article
Open access
PDF file
SLSophie Layalle
Sophie Layalle
LTLaetitia They
Laetitia They
SOSarah Ourghani
Sarah Ourghani
Cédric RaoulCédric Raoul
Cédric Raoul
LSLaurent Soustelle
Laurent Soustelle
Amyotrophic lateral sclerosis (ALS) is a devastating adult-onset neurodegenerative disease characterized by the progressive degeneration of upper and lower motoneurons. Most ALS cases are sporadic but approximately 10% of ALS cases are due to inherited mutations in identified genes. ALS-causing mutations were identified in over 30 genes with superoxide dismutase-1 (SOD1), chromosome 9 open reading frame 72 (C9orf72), fused in sarcoma (FUS), and TAR DNA-binding protein (TARDBP, encoding TDP-43) being the most frequent. In the last few decades, Drosophila melanogaster emerged as a versatile model for studying neurodegenerative diseases, including ALS. In this review, we describe the different Drosophila ALS models that have been successfully used to decipher the cellular and molecular pathways associated with SOD1, C9orf72, FUS, and TDP-43. The study of the known fruit fly orthologs of these ALS-related genes yielded significant insights into cellular mechanisms and physiological functions. Moreover, genetic screening in tissue-specific gain-of-function mutants that mimic ALS-associated phenotypes identified disease-modifying genes. Here, we propose a comprehensive review on the Drosophila research focused on four ALS-linked genes that has revealed novel pathogenic mechanisms and identified potential therapeutic targets for future therapy.

4 July 2013 in PLOS ONE
Verified
Journal Article
Open access
PDF file
YAYoan Arribat
Yoan Arribat
NBNathalie Bonneaud
Nathalie Bonneaud
YTYasmina Talmat-Amar
Yasmina Talmat-Amar
SLSophie Layalle
Sophie Layalle
MPMarie-Laure Parmentier
Marie-Laure Parmentier
FMFlorence Maschat
Florence Maschat
Huntington’s disease (HD) is caused by the abnormal expansion of the polyglutamine tract in the human Huntingtin protein (polyQ-hHtt). Although this mutation behaves dominantly, huntingtin loss of function also contributes to HD pathogenesis. Indeed, wild-type Huntingtin plays a protective role with respect to polyQ-hHtt induced defects. The question that we addressed here is what part of the wild-type Huntingtin is responsible for these protective properties. We first screened peptides from the Huntingtin protein in HeLa cells and identified a 23 aa peptide (P42) that inhibits polyQ-hHtt aggregation. P42 is part of the endogenous Huntingtin protein and lies within a region rich in proteolytic sites that plays a critical role in the pathogenesis process. Using a Drosophila model of HD, we tested the protective properties of this peptide on aggregation, as well as on different polyQ-hHtt induced neuronal phenotypes: eye degeneration (an indicator of cell death), impairment of vesicular axonal trafficking, and physiological behaviors such as larval locomotion and adult survival. Together, our results demonstrate high protective properties for P42 in vivo, in whole animals. These data also demonstrate a specific role of P42 on Huntington’s disease model, since it has no effect on other models of polyQ-induced diseases, such as spinocerebellar ataxias. Altogether our data show that P42, a 23 aa-long hHtt peptide, plays a protective role with respect to polyQ-hHtt aggregation as well as cellular and behavioral dysfunctions induced by polyQ-hHtt in vivo. Our study also confirms the correlation between polyQ-hHtt aggregation and neuronal defects. Finally, these results strongly suggest a therapeutic potential for P42, specific of Huntington’s disease.